Document is current
Any future updates will be listed below
-
Authors
Saadatian-Elahi, Mitra https://orcid.org/0000-0003-1265-8806
Alexander, Neal
Möhlmann, Tim
Ariffin, Farah Diana
Schmitt, Frederic
Richardson, Jason H.
Rabilloud, Muriel
Hamid, Nurulhusna Ab
-
Funding
Funding for this research was provided by:
Malaysian Ministry of Health
Bayer CropScience
IVCC
Fondation Innovations en Infectiologie
- License Information
-
More Information
Article History
Received: 27 October 2021
Accepted: 18 March 2022
First Online: 6 April 2022
Declarations
:
: The study protocol was submitted and approved by the IMR Research Management Committee and registered within the National Medical Research Register (NMRR-18–636-39710). The protocol has been also approved by the Malaysian Medical Ethics Research Committee (MREC) on Dec 2019 (KKM/NIHSEC/P19 – 2362–7). The trial protocol was registered with the ISRCTN registry on 17 April 2020 as ISRCTN81915073.
: Not applicable. There is no such information that need consent for publication.
: TM is remunerated by and hold shares in In2Care BV. FS is employee of Bayer. NA has salary support from the consortium funded in part by Bayer. Other authors do not have any competing interest to declare.
